GFAP and neoplasm: One patient (#7), who was the last of the patients with early progression to progress, experienced a detectable increase in CD9+/GFAP+/SVN+ exosomes 9 weeks following initial vaccination (Figure 4, row 4), which was 16 weeks prior to the detection of tumor progression on brain MRI scanning.